A Review of Recent Advances in Cell and Gene Therapy for HIV
DATE: January 5, 2022
TYPE: News
Researchers of a review worked to summarize notable advances in cell and gene therapy for HIV disease. Since there has been evidence for modulating disease, researchers note that cell and gene therapy in the HIV space has seen significant innovation.
CURATED BY: Sarah Smith
Sarah Smith
MHS, PA-C, AAHIVS
Chief Quality Officer, Philadelphia FIGHT
Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Participants With Preexisting Primary Integrase Inhibitor Resistance
DATE: November 11, 2022
TYPE: News
MEDIA TYPE: Document
Researchers examined virologic outcomes throughout 48 weeks of treatment with of bictegravir / emtricitabine / tenofovir alafenamide (B/F/TAF) in patients who have preexisting primary integrase strand transfer inhibitor resistance (INSTI-R)....
Antiretroviral therapy used to treat HIV have different drug classes that deal with the various stages of the HIV life cycle. The stages of the HIV life cycle are outlined...